Hold On to Hope: May is ALS Awareness Month

ALS Awareness Month

Annually, May observes ALS disease. Amyotrophic Lateral Sclerosis disease, sometimes referred as Lou Gehrig’s disease is a devastating progressive neurodegenerative disease which eventually will destroy a person’s ability to walk, speak, eat and breathe. As ALS is a progressive disease, more motor neurons are destroyed overtime worsening the symptoms, with breathing and swallowing being later symptoms; paralysis can also develop. After the onset of this disease, unfortunately fatality normally occurs within 2-5 years. Present day, there is no known treatment or cure for ALS. The aim of ALS Awareness Month is to raise awareness about ALS, gather support for those affected by this condition and to encourage funding and research into a treatment or cure. To learn more about ALS, and learn how to help find a cure, please visit www.alsa.org.

ALS Awareness Month infographic

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Spotlight On

Karam Mounzer, MD

Dr. Mounzer identified two major gaps in the care of patients with HIV/hepatitis C (HCV) co-infection, and the complexity of multidrug-resistant HIV treatment. He is involved with many clinical trials focusing on drug development and better understanding of HIV immunopathogenesis with the Wistar Institute. He is involved in teaching and mentoring fellows, residents and students.

Learn More about Spotlight On
Dr. Karam Mounzer

Dr. Mario Cruz

Dr. Cruz is a board certified pediatrician who joins Philadelphia FIGHT as the Medical Director for our Pediatrics and Adolescent Health Center. He completed his undergraduate training in Biology and Psychology from Union College, his medical school training at Albany Medical College, his residency training at St. Christopher’s Hospital for Children, and his Chief Residency at the Albert Einstein Medical Center